Custom-made "Nag" eye plaques for 125I brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 5, 2003, Pages 1373-1380

  Nag, Subir ^a   Wang, Dian ^a   Wu, Hong ^a   Bauer, Constance J ^a   Chambers, Robert B ^a   Davidorf, Frederick H ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Choroidal melanoma; Eye plaque; Iodine 125; Radiotherapy

Indexed keywords

OPHTHALMOLOGY; RADIOTHERAPY; VISION;

RETINOPATHY;

TUMORS;

IODINE 125;

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; BRACHYTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHOROID MELANOMA; CONTROLLED STUDY; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OPTIC DISK; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA LUTEA; RETINOPATHY; SCLERA; SUTURE; TUMOR GROWTH; TUMOR VOLUME; VISUAL ACUITY;

EID: 0038165026     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00324-9     Document Type: Article

References (23)

1. Finger P.T. Radiation therapy for choroidal melanoma (therapeutic review). Surv Ophthalmol. 42:1997;215-232.
2. Fontanesi J., Nag S. Brachytherapy for ocular disease. Nag S. Principles and practice of brachytherapy. 1997;291-304 Futura Publishing Company Inc. Armonk, NY.
3. Finger P.T., Buffa A., Mishra S., et al. Palladium-103 plaque radiation therapy for uveal melanoma. Clinical experience. Ophthalmology. 101:1994;256-263.
4. Finger P.T., Moshfeghi D.M., Ho T.K. Palladium-103 ophthalmic plaque radiation therapy. Arch Ophthalmol. 109:1991;1610-1613.
5. 106Rh beta-ray applicators. Surv Ophthalmol. 19:1974;85-100.
6. 106Rh plaque radiotherapy for malignant melanomas of the choroid. With follow-up results more than 5 years. Doc Ophthalmologica. 68:1988;225-238.
7. Fontanesi J., Meyer D., Shizhao X., et al. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys. 26:1993;619-623.
8. Sealy R., Buret E., Cleminshaw H., et al. Progress in the use of iodine therapy for tumors of the eye. Br J Radiol. 53:1980;1052-1060.
9. Stallard H.B. Radiobiology for malignant melanoma of the choroid. Br J Ophthalmol. 50:1966;147-155.
10. Davidorf F.H., Makley T.A., Lang J.R. Radiotherapy of malignant melanoma of the choroid. Trans Am Acad Ophthalmol Otolaryngol. 81:1976;849-861.
11. Davidorf F.H., Paika J.T., Makley T.A., et al. Radiotherapy of choroidal melanoma An 18-year experience with radon . Arch Ophthalmol. 105:1978;352-355.
12. 125I brachytherapy. Arch Ophthalmol. 105:1987;1394-1397.
13. 125I seeds. Acta Ophthalmol. 70:1992;780-785.
14. Lean E.K., Cohen D.M., Liggett P.E., et al. Episcleral radioactive plaque therapy Initial clinical experience with 56 patients . Am J Clin Oncol. 13:1990;185-190.
15. 106Rh) of choroidal melanomas 20 years experience . Br J Ophthalmol. 70:1986;844-885.
16. Packer S. Iodine-125 radiation of posterior uveal melanoma. Ophthalmology. 94:1987;1621-1626.
17. Packer S., Rotman M., Salanitro P. Iodine-125 irradiation of choroidal melanoma. Clinical experience. Ophthalmology. 91:1984;1700-1708.
18. 125I irradiation of uveal melanoma. Ophthalmology. 99:1992;767-774.
19. Potter P.D., Shields C.L., Shields J.A., et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Arch Ophthalmol. 114:1996;1357-1365.
20. The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of Iodine-125 brachytherapy for choroidal melanoma, II: Characteristics of patients enrolled and not enrolled. Arch Ophthalmol 2001;951-961.
21. The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma, III: Initial mortality findings. Arch Ophthalmol 2001;969-982.
22. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Committee Task Group No . 43. Med Phys. 22:1995;209-234.
23. Nag S, Quivey JM, Earle JD, et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 2003;56:544-555.